Urogen
Manufacturing · Indonesia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Jl. Musi No. 37 Jakarta, Jakarta Pusat, ...Website
www.urogen.co.idRevenue
$7 MillionIndustry
About Urogen
Urogen Org Chart
Is Urogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Urogen recently announced quarterly report
Funding: Get notified immidiatlly once Urogen has new funding data
Product Launch: Get notified when Urogen launches new products
Click to see if Urogen had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Urogen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Urogen is spiking on competitors!
Check if Urogen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Urogen
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Urogen as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Urogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Urogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Urogen.
Urogen Tech Stack
A closer look at the technologies used by Urogen
Urogen News & Media
UroGen (URGN) Q4 2025 Earnings Call Transcript
Joining me today are Elizabeth A. Barrett, President and Chief Executive Officer; Mark P. Schoenberg, Chief Medical Officer; David Lin, Chief Commercial Officer; and Christopher Degnan, Chief Financial Officer. On today's call, we will be making certain forward-looking statements.Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 28, 2025 in UroGen Pharma Ltd. Lawsuit – URGN
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd." or the "Company") (NASDAQ: URGN) of a class action securities lawsuit.Rosen Law Firm Urges UroGen Pharma Ltd. (NASDAQ: URGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of UroGen Pharms Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, both dates inclusive (the “Class Period”). UroGen engages in the development and commercialization of solutions for specialty cancers. For more information, submit a form, email attorney Phillip Kim, or give us a call atBiotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Inozyme Pharma (INZY), 1,125% surge in interest Affimed (AFMD), 866% surge in interest Acadia Pharmaceuticals (ACAD), 494% surge in interest UroGen Pharma (URGN), 214% surge in interest Cabaletta Bio (CABA), 144% surge in interest Pipeline and key clinical candidates for these companies: Inozyme Pharma is a clinical-stage biopharmaceutical company that sa
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Urogen
Urogen Advanced Solutions provides healthcare solutions tailored for hospitals and health clinics in Indonesia. Their flagship product is a portable pocket handheld ultrasound that offers best-in-class image quality at an affordable price, complemented by an easy-to-use AI-powered app. The company collaborates with leading brands such as AGFA, B-Br... Read More